McIlwain Matthew S 13D and 13G filings for Nautilus Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-08-25 8:58 pm Purchase |
2021-06-09 | 13D | Nautilus Biotechnology, Inc. NAUT |
McIlwain Matthew S | 6,368,136 5.130% |
6,368,136![]() (New Position) |
Filing |